The second option is to add a GLP-1 RA to the treatment regimen
Glucagon Like Peptide 1 Analogs Market Insights, By Application - Type 2 diabetes mellitus dominates the market, fueled by the increasing prevalence of t2dm and unmet clinical needs The Type 2 Diabetes Mellitus segment remains the largest application area for glucagon like peptide 1 analogs, driven primarily by the global surge in diabetes prevalence due to lifestyle changes, urbanization, and aging populations with an estimated share of 53.1% in 2026
Nutrients 16(17):2856 Viegas FvPD et al (2022) Curcumin, resveratrol and cannabidiol as natural key prototypes in drug design for neuroprotective agents
Body recomposition in the later months Months seven through twelve are where body recomposition becomes the primary focus for many people
If validated, this changes the OA treatment paradigm from symptom management to potential reversal
The product is designed to synergistically target two different physiological pathways of intermittent hypoxia (IH) and hypercapnia seen with OSA
